TI
REGN icon

Tidal Investments’s Regeneron Pharmaceuticals REGN Stock Holding History

Tidal Investments’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$27.4M Buy
43,896
+4,244
+11% +$2.89M 0.05% 388
2026
Q1 		$30.2M Buy
39,652
+24,251
+157% +$18.6M 0.06% 266
2025
Q4 		$11.9M Sell
15,401
-176
-1% -$120K 0.03% 409
2025
Q3 		$8.76M Buy
15,577
+2,297
+17% +$1.3M 0.02% 465
2025
Q2 		$6.97M Buy
13,280
+2,756
+26% +$1.54M 0.04% 393
2025
Q1 		$6.67M Buy
10,524
+2,809
+36% +$1.93M 0.05% 344
2024
Q4 		$5.5M Buy
7,715
+1,365
+21% +$1.15M 0.04% 394
2024
Q3 		$6.68M Buy
6,350
+510
+9% +$568K 0.07% 267
2024
Q2 		$6.14M Buy
5,840
+885
+18% +$858K 0.08% 225
2024
Q1 		$4.77M Buy
4,955
+711
+17% +$676K 0.08% 243
2023
Q4 		$3.73M Buy
4,244
+122
+3% +$100K 0.09% 201
2023
Q3 		$3.39M Sell
4,122
-2,178
-35% -$1.71M 0.1% 199
2023
Q2 		$4.53M Buy
6,300
+799
+15% +$616K 0.13% 140
2023
Q1 		$4.52M Sell
5,501
-2,717
-33% -$2.05M 0.15% 135
2022
Q4 		$5.93M Buy
8,218
+2,047
+33% +$1.51M 0.23% 87
2022
Q3 		$4.25M Sell
6,171
-1,027
-14% -$646K 0.18% 109
2022
Q2 		$4.25M Buy
7,198
+1,336
+23% +$868K 0.16% 116
2022
Q1 		$4.09M Sell
5,862
-371
-6% -$235K 0.12% 133
2021
Q4 		$3.94M Buy
6,233
+2,454
+65% +$1.51M 0.12% 132
2021
Q3 		$2.29M Buy
3,779
+2,109
+126% +$1.31M 0.09% 164
2021
Q2 		$933K Buy
1,670
+701
+72% +$355K 0.04% 304
2021
Q1 		$458K Buy
969
+199
+26% +$96.9K 0.02% 317
2020
Q4 		$372K Buy
770
+140
+22% +$75.6K 0.03% 272
2020
Q3 		$353K Buy
630
+82
+15% +$49.7K 0.05% 181
2020
Q2 		$342K Buy
548
+34
+7% +$19.3K 0.05% 199
2020
Q1 		$251K Buy
+514
New +$212K 0.07% 186

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Tidal Investments's REGN Position: Q2 2026 in Review

Tidal Investments increased its Regeneron Pharmaceuticals (REGN) stake by 11% in Q2 2026, buying an estimated $2.89M and bringing the position to 43,896 shares worth $27.4M. The position accounts for 0.05% of the portfolio, ranked #388.

Tidal Investments first reported a position in REGN in Q1 2020 and has held it in 26 quarters since. The position peaked at $30.2M in Q1 2026. 1,336 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Tidal Investments held 43,896 shares of Regeneron Pharmaceuticals worth $27.4M as of Q2 2026.
  • Tidal Investments bought 4,244 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $2.89M.
  • Regeneron Pharmaceuticals made up 0.05% of Tidal Investments's portfolio in Q2 2026, its #388 holding.
  • Tidal Investments first reported a position in Regeneron Pharmaceuticals in Q1 2020 and has held it in 26 quarters since.
  • Tidal Investments's Regeneron Pharmaceuticals position peaked at $30.2M in Q1 2026.
  • 1,336 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.